Phibro Animal Health Corporation
$ 34.29
-3.41%
07 Aug - close price
- Market Cap 1,440,047,000 USD
- Current Price $ 34.29
- High / Low $ 36.12 / 34.13
- Stock P/E 15.43
- Book Value 8.92
- EPS 2.30
- Next Earning Report 2026-08-26
- Dividend Per Share $0.48
- Dividend Yield 1.33 %
- Next Dividend Date 2026-09-23
- ROA 0.08 %
- ROE 0.30 %
- 52 Week High 59.83
- 52 Week Low 27.48
About
Phibro Animal Health Corporation develops, manufactures and supplies a range of mineral nutrition and animal health products for livestock primarily in the United States. The company is headquartered in Teaneck, New Jersey.
Analyst Target Price
$45.00
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-06 | 2026-02-04 | 2025-11-05 | 2025-08-27 | 2025-05-07 | 2025-02-05 | 2024-11-07 | 2024-08-28 | 2024-05-08 | 2024-02-07 | 2023-11-08 | 2023-08-30 |
| Reported EPS | 0.76 | 0.87 | 0.73 | 0.57 | 0.63 | 0.54 | 0.35 | 0.41 | 0.31 | 0.33 | 0.14 | 0.38 |
| Estimated EPS | 0.71 | 0.67 | 0.59 | 0.52 | 0.52 | 0.45 | 0.25 | 0.33 | 0.29 | 0.28 | 0.23 | 0.38 |
| Surprise | 0.05 | 0.2 | 0.14 | 0.05 | 0.11 | 0.09 | 0.1 | 0.08 | 0.02 | 0.05 | -0.09 | 0 |
| Surprise Percentage | 7.0423% | 29.8507% | 23.7288% | 9.6154% | 21.1538% | 20% | 40% | 24.2424% | 6.8966% | 17.8571% | -39.1304% | 0% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-26 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 0.72 |
| Currency | USD |
Previous Dividend Records
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-09-23 | 2026-06-24 | 2026-03-25 | 2025-12-17 | 2025-09-24 | 2025-06-25 | 2025-03-26 | 2024-12-18 | 2024-09-25 | 2024-06-26 |
| Amount | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 |
Next Dividend Records
| Dividend per share (year): | $0.48 |
| Dividend Yield | 1.33% |
| Next Dividend Date | 2026-09-23 |
| Ex-Dividend Date | 2026-09-02 |
Recent News: PAHC
2026-08-07 02:41:14
Daniel M Bendheim, President and CEO of Phibro Animal Health (PAHC), reported selling 486 shares of Class A Common Stock for $36.599 per share on August 4, 2026. This transaction was a broker-assisted cashless sale to cover tax withholding obligations associated with the vesting of restricted stock units. After the sale, Bendheim directly holds 3,478 shares.
2026-08-07 02:41:14
Phibro Animal Health's CFO, David Glenn, disposed of 840 shares of Class A Common Stock on August 4, 2026, at an average price of $36.599 per share. This transaction was a broker-assisted cashless exercise performed to satisfy tax withholding obligations related to the vesting of restricted stock units. Following this disposition, Glenn directly owns 51,477 shares of PAHC.
2026-08-07 02:41:14
Phibro Animal Health's General Counsel, Judith Weinstein, sold 472 shares of Class A Common Stock on August 4, 2026, at $36.599 per share. This transaction was a broker-assisted cashless exercise to cover tax withholding obligations upon the vesting of restricted stock units. Following this sale, Weinstein directly holds 2,975 shares of Class A Common Stock.
2026-08-07 02:41:14
Jack Bendheim, Executive Chairman and 10% owner of Phibro Animal Health (PAHC), disposed of 2,303 shares of Class A Common Stock on August 4, 2026. This transaction was conducted through a broker-assisted cashless exercise program to cover tax withholding obligations upon the vesting and settlement of restricted stock units. Following this, Bendheim directly holds 14,537 Class A shares and indirectly holds 56,152 shares through BFI Co., LLC.
2026-08-07 02:41:14
Phibro Animal Health's Chief Operating Officer, Larry Lee Miller, sold 635 shares of Class A Common Stock on August 4, 2026, at a price of $36.599 per share. This transaction was a broker-assisted cashless exercise to cover tax withholding obligations associated with the vesting of restricted stock units. Following the sale, Miller directly holds 34,549 shares of the company.
2026-08-06 19:41:14
FMR LLC and Abigail P. Johnson have reported a 15.0% beneficial ownership stake in Phibro Animal Health Corp's Class A common stock, totaling 3,160,280.92 shares as of June 30, 2026. FMR LLC holds sole voting power over 3,159,853 shares and sole dispositive power over all reported shares, while Abigail P. Johnson has sole dispositive power over the same amount but no voting power. This disclosure, filed as an amended Schedule 13G/A, indicates that other individuals may have dividend or sale proceeds rights but none exceed 5% ownership.
